Japanese Circulation Journal · 1995 · 32 citations · 5 references
MedicineCardiologyPharmacotherapyCardio-oncologyCardiovascular PharmacotherapyClinical CardiologyCancer Therapy-related CardiotoxicityCardiotoxicity ManagementCoronary Artery DiseaseIschemic Heart DiseaseMyocardial Infarction ComplicationsAcute Cardiac ToxicityAcute Myocardial Infarction DiagnosisCalcium Channel Blocker ToxicityCardiac Enzyme MarkersCardiac Enzyme TestingCardiotoxicityElectrocardiographic ChangesIschemic Cardiotoxicity
5-Fluorouracil (5-FU) is widely used in the treatment of various solid tumors. However, 5-FU cardiotoxicity is being reported with increasing frequency. The main symptom of cardiotoxicity is chest pain at rest with ischemic electrocardiographic changes. Up until now, the underlying mechanism has been suspected to be coronary artery spasm. However, this chest pain associated with 5-FU has several characteristics that are incompatible with coronary artery spasm; eg, inefficacy of calcium-channel blocker and a slow increase in cardiac enzyme levels. We experienced a case of 5-FU-induced cardiotoxicity which showed clinical findings consistent with acute myocardial infarction. Based on the clinical findings, coronary angiography, and left ventricular angiography in a prolonged attack, we concluded that the cardiotoxicity in this case was not due to ischemia caused by coronary artery spasm.
5
Cardiac Toxicity of 5-Fluorouracil: A Study on 1083 Patients
Roberto Labianca, Gianni Beretta, M. Clerici et al. · Tumori Journal · 1982 · 287 citations
Medicine, Oncology, Pharmacology +16
5-Fluorouracil cardiotoxicity.
A. Lomeo, Carlo Avolio, Gianluca Iacobellis et al. · PubMed · 1990 · 156 citations
Medicine, Oncology, Pharmacology +17
Prinzmetal's angina during 5-fluorouracil chemotherapy
Neal S. Kleiman, Daniel E. Lehane, Charles E. Geyer et al. · The American Journal of Medicine · 1987 · 105 citations
Medicine, Oncology, Pharmacology +7